glp-1 heart rate and health behavior responses to receptor agonists: a 12-wk study using wearable technology and causal inference | American Journal of Physiology-Heart and Circulatory Physiology Comprehensive Overview of GLP-1 RAs

PTEN is a tumor suppressor and phosphatase that negatively regulates phosphoinositide 3-kinases (PI3K), and its loss similarly leads to increased HIF-1 and VEGF (42)

SSD Acetyl L-Carnitine (ALCAR) delivers 2 g of pure amino acid per serve to support energy, fat metabolism, and cognitive function

Electrochemical and electrical biosensors for wearable and implantable electronics based on conducting polymers and carbon-based materials

A clinical study of a GLP-1 RA highlighted that participants who followed dietary advice and injected weekly saw an average 18% lower energy intake compared to placebo, with significant reductions in body weight and cardio-metabolic risk